FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2472426972> ?p ?o ?g. }

• W2472426972 endingPage "2015" @default.
• W2472426972 startingPage "2008" @default.
• W2472426972 abstract "ABSTRACT In January 2005, the National Institute for Health and Care Excellence (NICE) in England and Wales provided new guidance on the use of antiosteoporosis therapies for the secondary prevention of osteoporotic fractures. This was shortly followed in the same year by market authorization of a generic form of alendronic acid within the UK. We here set out to estimate the actual practice impact of these events among hip fracture patients in terms of antiosteoporosis medication prescribing and subsequent fracture incidence using primary care data (Clinical Practice Research Datalink) from 1999 to 2013. Changes in level and trend of prescribing and subsequent fracture following publication of NICE guidance and availability of generic alendronic acid were estimated using an interrupted time series analysis. Both events were considered in combination within a 1‐year “intervention period.” We identified 10,873 primary hip fracture patients between April 1999 and Sept 2012. Taking into account prior trend, the intervention period was associated with an immediate absolute increase of 14.9% (95% CI, 10.9 to 18.9) for incident antiosteoporosis prescriptions and a significant and clinically important reduction in subsequent major and subsequent hip fracture: –0.19% (95% CI, –0.28 to –0.09) and –0.17% (95% CI, –0.26 to –0.09) per 6 months, respectively. This equated to an approximate 14% (major) and 22% (hip) reduction at 3 years postintervention relative to expected values based solely on preintervention level and trend. We conclude that among hip fracture patients, publication of NICE guidance and availability of generic alendronic acid was temporally associated with increased prescribing and a significant decline in subsequent fractures. © 2016 American Society for Bone and Mineral Research." @default.
• W2472426972 created "2016-07-22" @default.
• W2472426972 creator A5002628934 @default.
• W2472426972 creator A5029564842 @default.
• W2472426972 creator A5030301769 @default.
• W2472426972 creator A5038076932 @default.
• W2472426972 creator A5049564443 @default.
• W2472426972 creator A5062863205 @default.
• W2472426972 creator A5079005099 @default.
• W2472426972 creator A5083543505 @default.
• W2472426972 date "2016-07-04" @default.
• W2472426972 modified "2023-10-16" @default.
• W2472426972 title "Anti‐Osteoporosis Medication Prescriptions and Incidence of Subsequent Fracture Among Primary Hip Fracture Patients in England and Wales: An Interrupted Time‐Series Analysis" @default.
• W2472426972 cites W1519774985 @default.
• W2472426972 cites W1558236383 @default.
• W2472426972 cites W1904766911 @default.
• W2472426972 cites W1964234489 @default.
• W2472426972 cites W1970450030 @default.
• W2472426972 cites W1976669401 @default.
• W2472426972 cites W1985434161 @default.
• W2472426972 cites W1989223960 @default.
• W2472426972 cites W2003929342 @default.
• W2472426972 cites W2004264048 @default.
• W2472426972 cites W2005298224 @default.
• W2472426972 cites W2009179975 @default.
• W2472426972 cites W2013724724 @default.
• W2472426972 cites W2032337714 @default.
• W2472426972 cites W2038278930 @default.
• W2472426972 cites W2041055356 @default.
• W2472426972 cites W2046617962 @default.
• W2472426972 cites W2050542368 @default.
• W2472426972 cites W2052297458 @default.
• W2472426972 cites W2077132229 @default.
• W2472426972 cites W2081073758 @default.
• W2472426972 cites W2093062840 @default.
• W2472426972 cites W2100245383 @default.
• W2472426972 cites W2102702396 @default.
• W2472426972 cites W2103185679 @default.
• W2472426972 cites W2110132657 @default.
• W2472426972 cites W2111366073 @default.
• W2472426972 cites W2119852447 @default.
• W2472426972 cites W2121640208 @default.
• W2472426972 cites W2145438333 @default.
• W2472426972 cites W2148912816 @default.
• W2472426972 cites W2163830908 @default.
• W2472426972 cites W2235358465 @default.
• W2472426972 cites W2256596564 @default.
• W2472426972 cites W2264427860 @default.
• W2472426972 doi "https://doi.org/10.1002/jbmr.2882" @default.
• W2472426972 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5122450" @default.
• W2472426972 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27377877" @default.
• W2472426972 hasPublicationYear "2016" @default.
• W2472426972 type Work @default.
• W2472426972 sameAs 2472426972 @default.
• W2472426972 citedByCount "60" @default.
• W2472426972 countsByYear W24724269722016 @default.
• W2472426972 countsByYear W24724269722017 @default.
• W2472426972 countsByYear W24724269722018 @default.
• W2472426972 countsByYear W24724269722019 @default.
• W2472426972 countsByYear W24724269722020 @default.
• W2472426972 countsByYear W24724269722021 @default.
• W2472426972 countsByYear W24724269722022 @default.
• W2472426972 countsByYear W24724269722023 @default.
• W2472426972 crossrefType "journal-article" @default.
• W2472426972 hasAuthorship W2472426972A5002628934 @default.
• W2472426972 hasAuthorship W2472426972A5029564842 @default.
• W2472426972 hasAuthorship W2472426972A5030301769 @default.
• W2472426972 hasAuthorship W2472426972A5038076932 @default.
• W2472426972 hasAuthorship W2472426972A5049564443 @default.
• W2472426972 hasAuthorship W2472426972A5062863205 @default.
• W2472426972 hasAuthorship W2472426972A5079005099 @default.
• W2472426972 hasAuthorship W2472426972A5083543505 @default.
• W2472426972 hasBestOaLocation W24724269722 @default.
• W2472426972 hasConcept C105795698 @default.
• W2472426972 hasConcept C120665830 @default.
• W2472426972 hasConcept C121332964 @default.
• W2472426972 hasConcept C126322002 @default.
• W2472426972 hasConcept C1862650 @default.
• W2472426972 hasConcept C187212893 @default.
• W2472426972 hasConcept C194828623 @default.
• W2472426972 hasConcept C199360897 @default.
• W2472426972 hasConcept C2426938 @default.
• W2472426972 hasConcept C2776541429 @default.
• W2472426972 hasConcept C2777251235 @default.
• W2472426972 hasConcept C2778885795 @default.
• W2472426972 hasConcept C2779256446 @default.
• W2472426972 hasConcept C2779809032 @default.
• W2472426972 hasConcept C2909024267 @default.
• W2472426972 hasConcept C33923547 @default.
• W2472426972 hasConcept C41008148 @default.
• W2472426972 hasConcept C61511704 @default.
• W2472426972 hasConcept C71924100 @default.
• W2472426972 hasConcept C98274493 @default.
• W2472426972 hasConceptScore W2472426972C105795698 @default.
• W2472426972 hasConceptScore W2472426972C120665830 @default.
• W2472426972 hasConceptScore W2472426972C121332964 @default.
• W2472426972 hasConceptScore W2472426972C126322002 @default.
• W2472426972 hasConceptScore W2472426972C1862650 @default.

• next